Free Trial

TriMas (NASDAQ:TRS) Receives Buy Rating from BWS Financial

TriMas logo with Industrial Products background

BWS Financial reaffirmed their buy rating on shares of TriMas (NASDAQ:TRS - Free Report) in a research note issued to investors on Tuesday, Benzinga reports. BWS Financial currently has a $40.00 target price on the industrial products company's stock.

TriMas Price Performance

NASDAQ TRS traded up $1.35 during trading hours on Tuesday, reaching $26.18. The company's stock had a trading volume of 503,782 shares, compared to its average volume of 266,373. The company has a quick ratio of 1.48, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. TriMas has a 1 year low of $22.45 and a 1 year high of $28.51. The firm's 50-day moving average price is $25.83 and its 200-day moving average price is $25.82. The company has a market capitalization of $1.06 billion, a price-to-earnings ratio of 40.41 and a beta of 0.66.

TriMas (NASDAQ:TRS - Get Free Report) last issued its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). The company had revenue of $229.36 million for the quarter, compared to the consensus estimate of $239.33 million. TriMas had a return on equity of 9.61% and a net margin of 4.44%. TriMas's revenue was down 2.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.57 EPS. On average, equities research analysts predict that TriMas will post 1.75 EPS for the current fiscal year.

TriMas Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th will be paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend is Tuesday, November 5th. TriMas's payout ratio is presently 25.00%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Quantbot Technologies LP lifted its position in TriMas by 5.7% during the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company's stock valued at $239,000 after purchasing an additional 478 shares during the last quarter. Algert Global LLC lifted its holdings in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company's stock valued at $403,000 after acquiring an additional 639 shares during the last quarter. Rhumbline Advisers grew its position in TriMas by 1.4% in the second quarter. Rhumbline Advisers now owns 69,328 shares of the industrial products company's stock worth $1,772,000 after acquiring an additional 985 shares in the last quarter. Innealta Capital LLC bought a new stake in TriMas during the second quarter worth approximately $26,000. Finally, Diversified Trust Co lifted its stake in shares of TriMas by 5.0% in the 2nd quarter. Diversified Trust Co now owns 22,719 shares of the industrial products company's stock valued at $581,000 after purchasing an additional 1,072 shares during the last quarter. 99.42% of the stock is owned by hedge funds and other institutional investors.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

See Also

Should you invest $1,000 in TriMas right now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines